DiscoverThe BioHub: The Top Voices in BiotechEpisode 96 - Jill Howe - CFO Lineage Cell Therapeutics
Episode 96 - Jill Howe - CFO Lineage Cell Therapeutics

Episode 96 - Jill Howe - CFO Lineage Cell Therapeutics

Update: 2025-12-03
Share

Description

Welcome to another Episode of The Biohub


Today, I’m joined by Jill Howe, Chief Financial Officer at Lineage Cell Therapeutics, a company developing groundbreaking allogeneic cell therapies for conditions like dry AMD, spinal cord injury, and hearing loss.


Jill’s career spans more than 20 years across some of biotech’s most successful companies, helping take both Receptos and Gossamer Bio public before stepping into her current role at Lineage.


We talk about what inspired her to join the company, how shehelps shape and protect Lineage’s culture, what excites her most about their pipeline, and her perspective on leadership and women in biotech.


Let’s get into it.

Comments 
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Episode 96 - Jill Howe - CFO Lineage Cell Therapeutics

Episode 96 - Jill Howe - CFO Lineage Cell Therapeutics

Max Brennan - Biotech HeadHunter